Answers are grounded in this paper and cite their sources.
The authors discuss findings that ramipril may reduce cardiovascular risk and improve arthritis markers in rheumatoid arthritis.
We read with great interest the recent issue of Arthritis Research & Th erapy i n which Shi and colleagues Th e authors concluded that ramipril reversed arthritis scoring and decreased markers of oxidative stress, infl ammation, and tissue fi brosis. Undoubtedly, their fi ndings will promote the attempt to diminish the cardiovascular risk of patients with rheumatoid arthritis (RA) by using angio tensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) or both.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: